What the Diagnostic Radiologist Needs to Know about Radiation Oncology
Authors:
- Stephanie A. TerezakisSTStephanie A. Terezakis
- Dwight E. HeronDHDwight E. Heron
- Ruth F. LavigneRLRuth F. Lavigne
- Maximilian DiehnMDMaximilian Diehn
- Billy W. LooBLBilly W. Loo
- 1 October 2011
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 261 (1) , 30-44
Abstract
Substantial technologic advances in radiation treatment planning and delivery have made possible exquisite tailoring of three-dimensional radiation dose distributions that conform to the tumor treatment volume while avoiding adjacent normal tissues. Although such highly precise treatment can increase the therapeutic ratio, it also introduces the potential that tumor extension outside the target is missed because it is unrecognized at the time of radiation treatment planning. As a result, accurate targeting of the tumor with radiation is of utmost importance to the radiation oncologist. Communication between diagnostic radiologists and radiation oncologists is essential, particularly given the subtleties that accompany image interpretation, to optimize the care of the cancer patient.Keywords
This publication has 69 references indexed in Scilit:
- Stereotactic ablative radiotherapy: what's in a name?Practical Radiation Oncology, 2011
- Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patientsPhysics in Medicine & Biology, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non–Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver MetastasesJournal of Clinical Oncology, 2009
- PET-CT in Radiation OncologyAmerican Journal of Clinical Oncology, 2008
- Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?Radiotherapy and Oncology, 2007
- Intraobserver and Interobserver Variability in GTV Delineation on FDG-PET-CT Images of Head and Neck CancersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence DevelopmentAmerican Journal of Roentgenology, 2007
- Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureLung Cancer, 2005